ArticleOncotarget2017

ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer.

Issam Chebouti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.